Clinical inhibits human T-cell activity through interaction with the PD-1 receptor.

Therapies that target and aid the host immune defense to repel cancer cells or invading pathogens are rapidly emerging. Antibiotic resistance is among the largest threats to human health globally. () is the most common bacterial infection, and it poses a challenge to the healthcare system due to its significant ability to develop resistance toward current available therapies.

induces cell-surface expression of immune stimulatory NKG2D ligands on human monocytes.

is among the leading causes of bacterial infections worldwide. The pathogenicity and establishment of infections are tightly linked to its ability to modulate host immunity. Persistent infections are often associated with mutant staphylococcal strains that have decreased susceptibility to antibiotics; however, little is known about how these mutations influence bacterial interaction with the host immune system.